Loading…
Lobbying Spend
—
Filings
53
Firms Hired
2
Active Period
2001–2013
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
HR 1548, Pathway for Biosimilars Act: entire bill. HR 4872, Health Care and Education Reconciliation Act of 2010: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. HR 3590: Patient Protection and Affordable Care Act; matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars.
Client expense: — · Firm income: $30,000
Matched citations: HR 1548
HR 1548, Pathway for Biosimilars Act; entire bill.
Client expense: — · Firm income: $50,000
Matched citations: HR 1548
HR 1548, Pathway for Biosimilars Act: entire bill. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform.
Client expense: — · Firm income: $50,000
Matched citations: HR 1548
HR 1548, Pathway for Biosimilars Act: entire bill. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform.
Client expense: — · Firm income: $50,000
Matched citations: HR 1548
HR 1548, Pathway for Biosimilars Act: entire bill. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform.
Client expense: — · Firm income: $50,000
Matched citations: HR 1548
HR 1548, Pathway for Biosimilars Act; entire bill.
Client expense: — · Firm income: $50,000
Matched citations: HR 1548
S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.
Client expense: — · Firm income: $50,000
Matched citations: HR 1908
HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.
Client expense: — · Firm income: $50,000
Matched citations: HR 5629
S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.
Client expense: — · Firm income: $50,000
Matched citations: S 1145
Biologics Price Competition and Innovation Act of 2007
2008 · fourth_quarter · Firm: THE OB-C GROUP, LLC
HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.
Client expense: — · Firm income: $50,000
Matched citations: S 1695
Paul Wellstone Mental Health and Addiction Equity Act of 2007
2008 · third_quarter · Firm: THE OB-C GROUP, LLC
HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics. HR 1367, Paul Wellstone Mental Health and Addiction Equity Act of 2007: mental health parity. HR 1424, Emergency Economic Stabilization Act of 2008: mental health parity.
Client expense: — · Firm income: $50,000
Matched citations: HR 1367
S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.
Client expense: — · Firm income: $50,000
Matched citations: HR 1908
HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics. HR 1367, Paul Wellstone Mental Health and Addiction Equity Act of 2007: mental health parity. HR 1424, Emergency Economic Stabilization Act of 2008: mental health parity.
Client expense: — · Firm income: $50,000
Matched citations: HR 5629
S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.
Client expense: — · Firm income: $50,000
Matched citations: S 1145
Biologics Price Competition and Innovation Act of 2007
2008 · third_quarter · Firm: THE OB-C GROUP, LLC
HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics. HR 1367, Paul Wellstone Mental Health and Addiction Equity Act of 2007: mental health parity. HR 1424, Emergency Economic Stabilization Act of 2008: mental health parity.
Client expense: — · Firm income: $50,000
Matched citations: S 1695
S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.
Client expense: — · Firm income: $50,000
Matched citations: HR 1908
HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.
Client expense: — · Firm income: $50,000
Matched citations: HR 5629
S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.
Client expense: — · Firm income: $50,000
Matched citations: S 1145
Biologics Price Competition and Innovation Act of 2007
2008 · second_quarter · Firm: THE OB-C GROUP, LLC
HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.
Client expense: — · Firm income: $50,000
Matched citations: S 1695
S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.
Client expense: — · Firm income: $50,000
Matched citations: HR 1908
Medicare Prescription Drug Price Negotiation Act of 2007
2008 · first_quarter · Firm: THE OB-C GROUP, LLC
S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.
Client expense: — · Firm income: $50,000
Matched citations: HR 4
S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.
Client expense: — · Firm income: $50,000
Matched citations: HR 5629
S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.
Client expense: — · Firm income: $50,000
Matched citations: S 1145
Biologics Price Competition and Innovation Act of 2007
2008 · first_quarter · Firm: THE OB-C GROUP, LLC
S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.
Client expense: — · Firm income: $50,000
Matched citations: S 1695
Medicare Prescription Drug Price Negotiation Act of 2007
2008 · first_quarter · Firm: THE OB-C GROUP, LLC
S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.
Client expense: — · Firm income: $50,000
Matched citations: S 3
Source: Senate LDA